Francesca Cicchetti

Vascular dysfunction in Huntington’s disease is located at the blood-CSF barrier and is rescued by sphingosine-1-phosphate receptor agonistpublié le 2025-05-05

Healthy blood, healthy brain: a window into understanding and treating neurodegenerative diseasespublié le 2024-06

Tau: a biomarker of Huntington’s diseasepublié le 2023-10

A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in ParkinsonAU disease: PleasenotethatParkinsonsdiseasehasbeenpublié le 2022

Prompting endogenous repair of brain injury: science fiction or reality?publié le 2022

Passive immunization against phosphorylated tau improves features of Huntington's disease pathologypublié le 2022-04

Correction: Shedding a new light on Huntington’s disease: how blood can both propagate and ameliorate disease pathology (Molecular Psychiatry, (2021), 26, 9, (5441-5463), 10.1038/s41380-020-0787-4)publié le 2021

Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins.publié le 2021-11-01

Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance.publié le 2021-10-28

Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience.publié le 2021-09-01

Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorderspublié le 2021-07

Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.publié le 2021-07-01

Huntington's disease: lessons from prion disorders.publié le 2021-02-24